CollPlant Biotechnologies (CLGN) Current Assets (2017 - 2026)

CollPlant Biotechnologies has reported Current Assets for 10 years, with the latest figure at $5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets fell 99.95% year-over-year to $5.5 million; the trailing twelve-month figure through Mar 2026 stood at $5.5 million (down 99.95% YoY), and the FY2025 full-year result was $6.7 million, down 99.95% from the prior year.
• Current Assets for Q1 2026 stood at $5.5 million, down from $6.7 million in the prior quarter.
• The five-year high for Current Assets was $31.7 billion in Q4 2022, with the low at $5.5 million in Q1 2026.
• Historically, Current Assets has averaged $8.1 billion across 5 years, with a median of $36.6 million in 2022.
• Annual changes were most pronounced in 2023 — Current Assets surged 90454.81% — and 2026, when it tumbled 99.95%.
• CollPlant Biotechnologies' Current Assets stood at $31.7 billion in 2022, then plunged by 99.91% to $28.0 million in 2023, then jumped by 46934.47% to $13.2 billion in 2024, then slumped by 99.95% to $6.7 million in 2025, then slipped by 17.9% to $5.5 million in 2026.
• The last three Current Assets figures came in at $5.5 million (Q1 2026), $6.7 million (Q4 2025), and $12.6 million (Q2 2025), per Business Quant data.